Literature DB >> 22939013

Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?

F Fanfani1, A Fagotti, M G Salerno, P A Margariti, M L Gagliardi, V Gallotta, G Vizzielli, G Panico, G Monterossi, G Scambia.   

Abstract

BACKGROUND: To examine the surgical treatment and clinical outcome of elderly and very elderly advanced epithelial ovarian cancer patients.
METHODS: We retrospectively analyzed FIGO stage IIIC-IV ovarian cancer patients, divided in elderly (Group A, >65 and <75 years) and very elderly patients (Group B, ≥ 75 years) treated by primary debulking surgery (PDS) or by interval debulking surgery (IDS) at the Catholic University at Rome and Campobasso, Italy.
RESULTS: 164 patients were included: 123 (Group A) and 41 (Group B). Complete cytoreduction was achieved in 60 patients (60.6%) in Group A and in 20 patients (62.5%) in Group B (p = 0.75). In the remaining cases, optimal cytoreduction was performed (39 cases (39.4%) in Group A and 12 (37.5%) in Group B; p = 0.75). In Group A complete/optimal debulking was achieved in 53 patients (53.5%) at PDS and in 46 patients (46.5%) at IDS (p = 0.55). In the Group B a higher rate of patients was debulked at IDS with respect to PDS (10 (31.3%) vs. 22 patients (68.7%); p = 0.02). In Group A patients debulked at PDS showed better DFS (p = 0.007) and OS (p = 0.003) with respect to patients submitted to successful IDS, whereas in group B we did not observed any survival difference according to time of cytoreduction.
CONCLUSIONS: Our data suggest that elderly and very elderly patients may tolerate radical and ultra-radical surgery. These patients should be managed in a gynecologic oncology unit, with prudent but complete approach.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22939013     DOI: 10.1016/j.ejso.2012.08.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  The Role of Artificial Intelligence in Managing Multimorbidity and Cancer.

Authors:  Alfredo Cesario; Marika D'Oria; Riccardo Calvani; Anna Picca; Antonella Pietragalla; Domenica Lorusso; Gennaro Daniele; Franziska Michaela Lohmeyer; Luca Boldrini; Vincenzo Valentini; Roberto Bernabei; Charles Auffray; Giovanni Scambia
Journal:  J Pers Med       Date:  2021-04-19

Review 2.  The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years.

Authors:  Steven J Gibson; Gini F Fleming; Sarah M Temkin; Dana M Chase
Journal:  Front Oncol       Date:  2016-03-24       Impact factor: 6.244

Review 3.  Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

Authors:  Lucia Tortorella; Giuseppe Vizzielli; Domenico Fusco; William C Cho; Roberto Bernabei; Giovanni Scambia; Giuseppe Colloca
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

4.  Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.

Authors:  Shuhua Zheng; Yuejun Fu
Journal:  Transl Oncol       Date:  2020-09-05       Impact factor: 4.243

5.  Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer.

Authors:  Emre Günakan; Yusuf Aytaç Tohma; Mehmet Tunç; Hüseyin Akıllı; Hanifi Şahin; Ali Ayhan
Journal:  Obstet Gynecol Sci       Date:  2019-12-31

6.  Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting.

Authors:  Michalis Liontos; Alkistis Papatheodoridi; Angeliki Andrikopoulou; Nikolaos Thomakos; Dimitrios Haidopoulos; Alexandros Rodolakis; Flora Zagouri; Aristotelis Bamias; Meletios-Athanasios Dimopoulos
Journal:  Curr Oncol       Date:  2021-03-07       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.